Browsing Tag
QuantiFERON
2 posts
Qiagen (NYSE: QGEN) at a crossroads ahead of new CEO and Q1 2026 results
Qiagen (NYSE: QGEN) retail investor roadmap: strategic review, CEO search, 2026 product pipeline and what the May earnings call means for shareholders.
April 3, 2026
QIAGEN files lawsuit against bioMérieux to defend QuantiFERON patents and innovation in TB diagnostics
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) has initiated legal proceedings against bioMérieux S.A. (EPA: BIM) in…
March 3, 2025